Remove Blogging Remove Conference Remove Journal Remove Pricing
article thumbnail

Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More

Xconomy

—As the North American Cystic Fibrosis Conference kicked off in Orlando, FL, Vertex Pharmaceuticals (NASDAQ: VRTX ) said a key part of its plan to defend its industry-leading cystic fibrosis franchise is moving forward. THIS WEEK IN DRUG PRICING…. —A coalition of investors pressed drug makers to justify price increases.

Pricing 40
article thumbnail

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

Xconomy

The firm will now focus on its miniLab, which CEO Elizabeth Holmes touted as a follow-on version of its Edison test system at a scientific conference in August. PRICE FIGHTS. With some caveats, ICER recommended lower prices. She refused to discuss Edison at the time. for their work on molecular machines.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More

Xconomy

The companies—Amgen, Sanofi, and Regeneron Pharmaceuticals—are due to release important long-term data next year that will shape the debate over the drugs’ prices. With the benefit of peer review, the publication garnered international headlines but disclosed little new information beyond what Biogen described last year. .

News 57
article thumbnail

Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes

Xconomy

This weekend, much of academia and industry involved in cancer will gather in Chicago for the annual American Society of Clinical Oncology conference. A company official told Xconomy the drug would be priced in line with standard of care enzyme replacement therapy, which costs around $300,000 per patient, per year.

article thumbnail

Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More

Xconomy

Just as many M&A rumors flame out as lead to deals, of course, but the news was enough to give Biogen’s stock price a big bump, and ignite chatter about what a sale of one of biotech’s heavyweights would mean, particularly for the Boston area. The rumors boosted Biogen’s sinking stock price nearly 10 percent.

News 40
article thumbnail

Tech Titans Peter Thiel, Matt Jacobson, Cameron and Tyler Winklevoss, Mich Mathews, Elon Musk Buy Homes in Los Angeles

SoCal Delicious

Professor Journal. Student Journal. Developments Blog. Prices are soaring in the beachfront communities tech types favor, and rents in these. Mark Holtzman for The Wall Street Journal. Mark Holtzman for The Wall Street Journal). Prices have gone up dramatically on this beachfront strip. MarketWatch.

article thumbnail

Frank Addantes FounderBlog: Setting up Shop - Picking an Office Space

Frank Addante

About Frank Addante > (from the Silicon Valley Business Journal) Twitter Updates follow me on Twitter Blog Archive ► 2010 (2) ► June (1) Part II: Optimized for Profitability ► February (1) Get Out of the Office! ► October (1) New Video! Expansion possibilities are slim.

Startup 40